Imidazoline derivatives: a patent review (2006 – present)

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.11, 2012-11, pp. : 1353-1365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quinoxaline derivatives: a patent review (2006 – present)

By González Mercedes Cerecetto Hugo

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 11, 2012-11 ,pp. : 1289-1302

Informa Healthcare

Access to resources Recommend Favorite

Artemisinin derivatives: a patent review (2006 – present)

By Njuguna Nicholas M Ongarora Dennis S B Chibale Kelly

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 10, 2012-10 ,pp. : 1179-1203

Informa Healthcare

Access to resources Recommend Favorite

Phenylpiperazine derivatives: a patent review (2006 – present)

By Maia Rodolfo do Couto Tesch Roberta Fraga Carlos Alberto Manssour

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 10, 2012-10 ,pp. : 1169-1178

Informa Healthcare

Access to resources Recommend Favorite

Dendrimer and cancer: a patent review (2006 – present)

By Cai Xiaopan Hu Jingjing Xiao Jianru Cheng Yiyun

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 515-529

Informa Healthcare

Access to resources Recommend Favorite

Pyrazine derivatives: a patent review (2008 – present)

By Ferreira Sabrina Baptista Kaiser Carlos Roland

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 9, 2012-09 ,pp. : 1033-1051

Informa Healthcare

Access to resources Recommend Favorite